Search Results 1741-1750 of 17935 for STI Prevention

1. Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS) - Mayo Clinic

   This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or R/R SLL pretreated with ...

2. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

   (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive. Print ...

3. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

   About this study · Cohort A: Colorectal cancer (CRC); · Cohort B: Gastric and gastroesophageal junction (GEJ) cancer; · Cohort C: Triple-negative breast cancer ( ...

4. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

5. Study of Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK) - Mayo Clinic

   The purpose of this study is to to determine the safety and effectivness of a single dose of autologous polyTregs or darTregs in renal transplant recipients ...

6. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...

7. A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer - Mayo Clinic

   The purpose of this study is to confirm that adding custirsen to standard first-line docetaxel and prednisone treatment can slow tumor progression in men who ...

8. A Study to Find RNA Markers that Describe the Underlying Inflammatory Process and Can Help Direct Therapy - Mayo Clinic

   The purpose of the study is to find specific and sensitive RNA markers that not only describe the underlying inflammatory process, but can help direct therapy ...

9. Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers - Mayo Clinic

   Enzalutamide is not FDA approved to treat salivary gland cancer, but it has already been FDA-approved to treat other cancers. Participation eligibility.

10. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate perianal fistula healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram (mg) in ...